Exploring Regulatory and Reimbursement Pathways for DTx: Asia Pacific

Join us for a webinar series where we delve into the complexities of regulatory and reimbursement pathways for digital therapeutics around the globe. Each session in this series will focus on a specific country or region, providing a comprehensive overview of the landscape for digital therapeutics.

In this session, we will focus on a specific the Asia-Pacific region, providing a comprehensive overview of the regulatory and reimbursement frameworks for digital therapeutics. We will review the frameworks in countries including South Korea, Japan, China, Singapore, and Australia.

Join us to hear from our experts who have navigated these pathways, gaining valuable insights from their experiences and strategies, and answering question including:

• What are the regulatory pathways?
• What are the reimbursement pathways?
• How is the reimbursement pathway impacted by the regulatory pathway?
• How successful are companies in each pathway to date?
• What does a company need to do to be successful in each pathway?
• How do we see the pathways evolving in the next 5 years?

Speakers:

• Dr. Chungkeun Lee, Professor for Research and Cooperation, Seoul National University Bundang Hospital
• Grace Lethlean, Chief Product Officer, ANDHealth
• Nishit Patadia, Engagement Manager, EVERSANA APAC
• Moderator: Roberta Sarno, Head of APAC Policy, Digital Therapeutics Alliance

Host or Publisher Digital Therapeutics Alliance